Patent ID: 11931359
Assignee: SUN PHARMA ADVANCED RESEARCH COMPANY LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  B | IPC A  B

Claim 14:
15. The method of claim 11, wherein the formulation comprises 0.35% w/v brimonidine tartrate, 0.35% w/v sodium polystyrene divinyl benzene sulphonate, 0.3% w/v hydroxypropyl methylcellulose, 1.2% w/v polyvinylpyrrolidone, 0.1% w/v carbomer, benzalkonium chloride, 0.1% w/v edetate disodium, 0.06% N-lauroylsarcosine sodium, 4.5% w/v mannitol, 0.32% w/v tromethamine, and water for injection.